These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30697035)

  • 1. Incidence and prevalence of vitreomacular traction with and without macular hole in Germany.
    Menzler J; Neubauer AS; Haritoglou C; Jackson TL
    Clin Ophthalmol; 2019; 13():177-188. PubMed ID: 30697035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocriplasmin for symptomatic vitreomacular adhesion.
    Neffendorf JE; Kirthi V; Pringle E; Jackson TL
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD011874. PubMed ID: 29040800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal gas for symptomatic vitreomacular adhesion: a synthesis of the literature.
    Neffendorf JE; Simpson ARH; Steel DHW; Desai R; McHugh DA; Pringle E; Jackson TL
    Acta Ophthalmol; 2018 Nov; 96(7):685-691. PubMed ID: 28857483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PNEUMATIC VITREOLYSIS VERSUS PARS PLANA VITRECTOMY IN FOCAL SYMPTOMATIC VITREOMACULAR TRACTION SYNDROME: A Randomized Trial.
    Kumar V; Sonkar R; Verma S; Azad SV; Chawla R; Venkatesh P; Vohra R; Kumar A
    Retina; 2022 Jul; 42(7):1277-1283. PubMed ID: 35723920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptomatic vitreomacular adhesion.
    Jackson TL; Nicod E; Simpson A; Angelis A; Grimaccia F; Kanavos P
    Retina; 2013 Sep; 33(8):1503-11. PubMed ID: 23714857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective cohort study in patients with tractional diseases of the vitreomacular interface (ReCoVit).
    Stalmans P
    Graefes Arch Clin Exp Ophthalmol; 2016 Apr; 254(4):617-28. PubMed ID: 26899900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole.
    Duker JS; Kaiser PK; Binder S; de Smet MD; Gaudric A; Reichel E; Sadda SR; Sebag J; Spaide RF; Stalmans P
    Ophthalmology; 2013 Dec; 120(12):2611-2619. PubMed ID: 24053995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term evaluation of vitreomacular traction disorder in spectral-domain optical coherence tomography.
    Odrobina D; Michalewska Z; Michalewski J; Dzięgielewski K; Nawrocki J
    Retina; 2011 Feb; 31(2):324-31. PubMed ID: 21416651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocriplasmin Treatment Leads to Symptomatic Vitreomacular Adhesion/Vitreomacular Traction Resolution in the Real-World Setting: The Phase IV ORBIT Study.
    Khanani AM; Duker JS; Heier JS; Kaiser PK; Joondeph BC; Kozma P; Rosberger DF; MacCumber M; Boyer DS; Pieramici DJ
    Ophthalmol Retina; 2019 Jan; 3(1):32-41. PubMed ID: 30935657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmaological vitreolysis with ocriplasmin as a treatment option for symptomatic focal vitreomacular traction with or without macular holes (≤400 μm) compared to tranconjunctival vitrectomy].
    Maier M; Abraham S; Frank C; Lohmann CP; Feucht N
    Ophthalmologe; 2017 Feb; 114(2):148-154. PubMed ID: 27444007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. THE EFFECT OF ELECTIVE CATARACT EXTRACTION BY PHACOEMULSIFICATION IN EYES WITH VITREOMACULAR TRACTION SYNDROME.
    Mantopoulos D; Prenner JL; Patel VK; Roth DB; Shah SP; Tsavaris O; Fine HF; Wheatley HM
    Retina; 2021 Jan; 41(1):75-81. PubMed ID: 32106158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of ocriplasmin for the treatment of vitreomacular traction and macular hole.
    Bennison C; Stephens S; Lescrauwaet B; Van Hout B; Jackson TL
    J Mark Access Health Policy; 2016; 4():. PubMed ID: 27429719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Efficacy and Safety Profile of Ocriplasmin in Vitreomacular Interface Disorders.
    Shaikh M; Miller JB; Papakostas TD; Husain D
    Semin Ophthalmol; 2017; 32(1):52-55. PubMed ID: 27786583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical Results in Ocriplasmin Candidates With Symptomatic Vitreomacular Traction Syndrome.
    Vasquez DH; Altamirano JC; Casaus A; Del Valle RA; Gonzalez R; Gonzalez-De La Rosa A; Navarro-Partida J; Vasquez MA; Santos A
    Curr Eye Res; 2018 Feb; 43(2):208-212. PubMed ID: 29111823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of phacoemulsification on posterior vitreous detachment formation in eyes with vitreomacular traction.
    Tieger MG; Vavvas DG
    Digit J Ophthalmol; 2023; 29(2):26-30. PubMed ID: 37727466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anatomical and visual outcomes following ocriplasmin treatment for symptomatic vitreomacular traction syndrome.
    Singh RP; Li A; Bedi R; Srivastava S; Sears JE; Ehlers JP; Schachat AP; Kaiser PK
    Br J Ophthalmol; 2014 Mar; 98(3):356-60. PubMed ID: 24357495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous resolution of vitreomacular traction demonstrated by spectral-domain optical coherence tomography.
    Theodossiadis GP; Grigoropoulos VG; Theodoropoulou S; Datseris I; Theodossiadis PG
    Am J Ophthalmol; 2014 Apr; 157(4):842-851.e1. PubMed ID: 24445034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profile of ocriplasmin and its potential in the treatment of vitreomacular adhesion.
    Stefanini FR; Maia M; Falabella P; Pfister M; Niemeyer M; Kashani AH; Humayun MS; Koss MJ
    Clin Ophthalmol; 2014; 8():847-56. PubMed ID: 24851038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of vitreomacular adhesion in eyes with macular oedema secondary to retinal vein occlusion selected for intravitreal injections.
    Maggio E; Maraone G; Mete M; Vingolo EM; Grenga PL; Guerriero M; Pertile G
    Acta Ophthalmol; 2021 Nov; 99(7):e1154-e1161. PubMed ID: 33421346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macular hole formation and spontaneous closure after vitrectomy for vitreomacular traction documented in spectral-domain optical coherence tomography.
    Odrobina D; Laudańska-Olszewska I; Gozdek P; Maroszyński M; Amon M
    BMC Ophthalmol; 2014 Feb; 14():17. PubMed ID: 24552161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.